Clearwater Analytics Holdings, Inc. (CWAN) Research

Clearwater Analytics Holdings, Inc. offers a cloud-based (Software-as-a-Service) platform engineered to automate and centralize the entire lifecycle of investment data. This encompasses aggregation, reconciliation, comprehensive accounting, and detailed reporting capabilities for a diverse clientele, including insurers, asset managers, corporations, institutional investors, and government entities. Their robust suite of solutions spans critical areas such as investment accounting and reporting, performance measurement, continuous compliance monitoring, and sophisticated risk analytics. A core offering, Clearwater Prism, grants users self-service access to consolidated data feeds originating from various systems—both Clearwater's proprietary platforms and those of external third-party vendors—covering accounting, compliance, performance, and risk domains. It also facilitates highly adaptable reporting functionalities for different stakeholders. Established in 2021, the company's headquarters are located in Boise, Idaho.

Market snapshot

Symbol
CWAN
Price
$24.29
Day change
+0.12%
Market cap
$7.2B
P/E ratio
-148.99x
52-week range
15.735-24.43
Sector
Technology
Industry
Software - Application
Next earnings
in 2 months
Analyst price target
$24.55

Peer companies

  • ACI Worldwide, Inc. (ACIW)
  • Bill.com Holdings, Inc. (BILL)
  • Bitdeer Technologies Group (BTDR)
  • Webull Corporation Class A Ordinary Shares (BULL)
  • Diginex Limited (DGNX)
  • JFrog Ltd. (FROG)
  • Ingram Micro Holding Corporation (INGM)
  • WEX Inc. (WEX)

Recent insider activity

  • MACKESY D SCOTT — S-Sale (633879 shares) on 2026-06-15
  • Hooper Christopher — G-Gift (30000 shares) on 2026-06-15
  • Das Souvik — S-Sale (10000 shares) on 2026-06-08
  • MACKESY D SCOTT — C-Conversion (292180 shares) on 2026-05-28
  • MACKESY D SCOTT — C-Conversion (292180 shares) on 2026-05-28

Open Clearwater Analytics Holdings, Inc. (CWAN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.